pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
AMPHOTERICIN B LIPOSOME
AMPHOTERICIN B LIPOSOME (AMPHOTERICIN B LIPOSOME)
MYLAN LABS LTD
0 catalysts
AMPICILLIN SODIUM AND SULBACTAM SODIUM
AMPICILLIN SODIUM AND SULBACTAM SODIUM (AMPICILLIN SODIUM, SULBACTAM SODIUM)
ONESOURCE SPECIALTY
0 catalysts
Phase 2
AMT-162
Amyotrophic Lateral Sclerosis
UniQure NV
0 catalysts
Phase 2
AMT-191
Fabry Disease
UniQure NV
0 catalysts
← prev
page 53 of 231
next →
131
Pain89
Neurology1
Phase 2
AMT-260
Epilepsy
UniQure NV
0 catalysts
Phase 1
AMT-754
Bladder Cancer
ADCendo ApS
0 catalysts
Phase 2
AMTX-100
Atopic Dermatitis (Atopic Eczema)
Amytrx Therapeutics Inc
0 catalysts
Phase 1
AMX-0114
Amyotrophic Lateral Sclerosis
$AMLXAmylyx Pharmaceuticals, Inc.
0 catalysts
Preclinical
AMX-883
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Amphista Therapeutics Ltd
0 catalysts
AMYVID
AMYVID (FLORBETAPIR F 18)
AVID RADIOPHARMS INC
0 catalysts
Preclinical
AMZ-004
Chemotherapy Induced Nausea and Vomiting
Amzell Limited
0 catalysts
Phase 1
AN-4005
Diffuse Large B-Cell Lymphoma
Adlai Nortye Biopharma Co Ltd
0 catalysts
Phase 1
AN-9025
Bile Duct Cancer (Cholangiocarcinoma)
Adlai Nortye Biopharma Co Ltd
0 catalysts
ANAGRELIDE
ANAGRELIDE (ANAGRELIDE)
TORRENT
0 catalysts
ANALPRAM HC
ANALPRAM HC (HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE)
LEGACY PHARMA
0 catalysts
Phase 2
ANAVEX-371
Schizophrenia
$AVXLANAVEX LIFE SCIENCES CORP.
0 catalysts
Phase 2
AND-017
Anemia in Chronic Kidney Disease (Renal Anemia)
Kind Pharmaceuticals
0 catalysts
Phase 1
AND-019
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Kind Pharmaceuticals
0 catalysts
Phase 1
ANK-700
Relapsing Remitting Multiple Sclerosis (RRMS)
Anokion SA
0 catalysts
Phase 1
ANP-390
Peripheral Neuropathic Pain
AlphaNavi Pharma Inc
0 catalysts
Phase 2
ANS-01
Non-Small Cell Lung Cancer
Avistone Biotechnology Co Ltd
0 catalysts
Phase 1
ANS-03
Solid Tumor
Avistone Biotechnology Co Ltd
0 catalysts
Preclinical
ANT-308 Fc3
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Cambium Oncology LLC
0 catalysts
ANTI DIARRHEAL
ANTI DIARRHEAL (LOPERAMIDE HCL)
PERRIGO R AND D
0 catalysts
ANTI DIARRHEAL ANTI GAS
ANTI DIARRHEAL ANTI GAS (LOPERAMIDE HYDROCHLORIDE, SIMETHICONE)
PERRIGO R AND D
0 catalysts
ANTI-DIARRHEAL/ANTI-GAS MULTI-SYMPTOM RELIEF
ANTI-DIARRHEAL/ANTI-GAS MULTI-SYMPTOM RELIEF (LOPERAMIDE HYDROCHLORIDE 2MG, SIMETHICONE 125MG)
GUARDIAN DRUG
0 catalysts
Preclinical
ANV-221
Pancreatic Cancer
Anviron Corp
0 catalysts
Phase 2
ANV-419
Metastatic Melanoma
Anaveon AG
0 catalysts
Phase 2
ANV-600
Melanoma
Anaveon AG
0 catalysts
Phase 2
ANXV
Retinal Vein Occlusion
Annexin Pharmaceuticals AB
0 catalysts